Welcome to our dedicated page for Selectis Health SEC filings (Ticker: GBCS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Selectis Health, Inc. (GBCS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed information about Selectis Health’s healthcare facility portfolio, financing arrangements, and corporate governance decisions, complementing the company’s press releases.
For Selectis Health, Current Reports on Form 8-K are particularly important. Recent 8-K filings have disclosed material events such as definitive purchase and sale agreements for skilled nursing facilities in Georgia, related operations transfer agreements, and the terms of a Third Amended and Restated Allonge and Modification Agreement for senior secured promissory notes. Other 8-Ks describe appointments of new board members and changes in leadership roles, providing context on the company’s governance and oversight.
Investors can also review Selectis Health’s periodic reports, such as Forms 10-Q and 10-K, which include discussions of healthcare operations, facility performance, and revisions to previously issued financial statements, as referenced in the company’s communications. These filings may address topics like revenue from healthcare operations, operating expenses, and revisions related to accounting for healthcare revenue and intercompany transactions.
On Stock Titan, AI-powered summaries help explain the key points in lengthy filings, highlighting items such as transaction terms, maturity extensions for debt, warrant modifications, and board appointments. Real-time updates from EDGAR ensure that new filings appear promptly, while Form 4 and related insider transaction reports, when filed, can be used to track equity dealings by directors and officers. This page is intended as a centralized view of Selectis Health’s regulatory history, enabling users to quickly understand the substance of each filing without reading every page in full.
Selectis Health, Inc. completed the sale of two skilled nursing facilities in Georgia through wholly owned subsidiaries, transferring substantially all related real and personal property. The Sparta and Warrenton facilities were sold for an aggregate purchase price of $13.175 million, subject to customary prorations, holdbacks and adjustments, with $1.3 million placed in escrow that may be released to the sellers if no indemnity claims arise. The company retained rights to collect tenant amounts related to periods before closing. A substantial portion of the net proceeds was used to pay in full a facility mortgage, note obligations, a contractual obligation, transaction costs and other expenses, with the remaining balance expected to support working capital. Concurrently, operations of the facilities were transferred from the prior controlled operators to new operators affiliated with the purchasers, without additional consideration.
Selectis Health, Inc. director Kent J. Lund filed an initial ownership report listing his beneficial holdings of the company’s voting common shares. He reports direct ownership of 15,992 voting common shares and indirect beneficial ownership of 3,261 voting common shares held through his spouse’s IRA. This filing establishes his starting ownership position as of January 1, 2026.
Selectis Health, Inc. director and 10% owner Lance Baller filed a Form 4 reporting an indirect purchase of common stock. On December 18, 2025, an entity named High Speed Aggregate, Inc. acquired 6,192 shares of Selectis Health common stock at $2.20 per share, reported as an indirect beneficial holding for Baller.
After this transaction, Baller is listed as beneficially owning 161,965 shares of common stock directly. Indirectly, he is shown with 52,808 shares of common stock through High Speed Aggregate, Inc., 72,934 shares of common stock and 55,000 warrants through Ultimate Investments Corp., Inc., and 6,667 shares of common stock through Baller Family Foundation, Inc.
Selectis Health, Inc. reported that effective January 1, 2026, its Board of Directors appointed Kent J. Lund and Lance Baller as members of the Board. Lund is a seasoned business, legal, and securities professional with experience as a federal court of appeals law clerk, large-firm attorney, in-house counsel to a major multinational energy company, and senior executive and compliance officer at broker-dealers and investment advisers. He has also served on the Colorado Securities Board, the FINRA West Region Committee, and the board and audit committee of a private broadband company.
Baller, age 51, is co‑founder and non‑executive chairman of Iofina Plc and has previously served as its CFO and CEO. He has led and owned multiple private businesses across mining, equipment leasing, real estate, and professional services, and founded the Baller Family Foundation. From 2015 to 2023 he served as CEO, Interim CEO, and Director of Selectis Health, bringing prior company-specific leadership experience. His background includes hedge fund management, mergers and acquisitions advisory work, investment banking roles at UBS and Morgan Stanley, and extensive audit committee and board service for mutual funds and ETFs.
Selectis Health, Inc. reported that it entered into a Third Amended and Restated Allonge and Modification Agreement covering its 2018 11% Senior Secured Promissory Notes, with an aggregate principal of
The company also extended the expiration date of warrants previously granted to the noteholders to
Selectis Health, Inc. reported that two wholly owned subsidiaries entered into a definitive Purchase and Sale Agreement to sell substantially all real and personal property of two skilled nursing facilities in Georgia. The facilities, Providence of Sparta Health & Rehab in Sparta and Warrenton Health and Rehabilitation in Warrenton, are being sold to entities affiliated with Journey Propco for a total purchase price of
At the same time, the operating subsidiaries signed an Operations Transfer Agreement with new operator entities affiliated with the buyers, which will govern transfer of the skilled nursing operations if the property sale closes. Both agreements are subject to completion of due diligence and other customary conditions, and the company notes there can be no assurance that these transactions will be consummated.
Selectis Health, Inc. (GBCS) reported Q3 2025 results showing healthcare revenue of $10,839,954 versus $10,016,416 a year ago, driven by higher Medicaid rates in Georgia and Oklahoma. Net income was $752,365 compared to a prior-year loss, aided by $659,923 from employee retention credits and higher other income.
For the nine months, the company recorded a net loss of $211,631 versus $1,847,498 last year, with interest expense lower on reduced debt. Liquidity remains tight: cash was $417,125 and restricted cash $806,886 as of September 30, 2025, with a working capital deficit of approximately $16.3 million. Total debt, net of discount, was $31,126,545, and the company disclosed noncompliance with two loan covenants, classifying related amounts as current. Management noted substantial doubt about continuing as a going concern and outlined plans to increase occupancy and rates, control costs, and seek capital. As of November 12, 2025, common shares outstanding were 3,067,059.
FAQ
What is the current stock price of Selectis Health (GBCS)?
What is the market cap of Selectis Health (GBCS)?
